Gene · 2255
Papers3,603
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,603
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TWEAK Signaling-Induced ID1 Expression Drives Malignant Transformation of Hepatic Progenitor Cells During Hepatocarcinogenesis. | Adv Sci (Weinh) | 2023 | 37085918 | PubTator, text mining | PubMed |
| Transcriptomic analysis of lung development in wildtype and CFTR-/- sheep suggests an early inflammatory signature in the CF distal lung. | Funct Integr Genomics | 2023 | 37085733 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the developmental program underlying proximal-distal patterning of the human lung at the embryonic stage. | Cell Res | 2023 | 37085732 | PubTator, text mining | PubMed |
| PRDM1 DNA-binding zinc finger domain is required for normal limb development and is disrupted in split hand/foot malformation. | Dis Model Mech | 2023 | 37083955 | PubTator, text mining | PubMed |
| Long-term organoid culture of a small intestinal neuroendocrine tumor. | Front Endocrinol (Lausanne) | 2023 | 37082125 | PubTator, text mining | PubMed |
| Identification of a novel mutation in the FGF10 gene in a Chinese family with obvious congenital lacrimal duct dysplasia in lacrimo-auriculo-dento-digital syndrome. | Int J Ophthalmol | 2023 | 37077496 | PubTator, text mining | PubMed |
| Perinatal origins of bronchopulmonary dysplasia-deciphering normal and impaired lung development cell by cell. | Mol Cell Pediatr | 2023 | 37072570 | PubTator, text mining | PubMed |
| Bladder cancer organoids as a functional system to model different disease stages and therapy response. | Nat Commun | 2023 | 37072390 | PubTator, text mining | PubMed |
| Single-cell profiling of GP2-enriched pancreatic progenitors to simultaneously create acinar, ductal, and endocrine organoids. | Theranostics | 2023 | 37064874 | PubTator, text mining | PubMed |
| High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancer. | Breast Cancer Res Treat | 2023 | 37061618 | PubTator, text mining | PubMed |
| Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention. | Front Pharmacol | 2023 | 37056987 | PubTator, text mining | PubMed |
| CHARGE syndrome-associated CHD7 acts at ISL1-regulated enhancers to modulate second heart field gene expression. | Cardiovasc Res | 2023 | 37052590 | PubTator, text mining | PubMed |
| Ultrasound-guided fine-needle aspiration/biopsy-based pancreatic organoids establishment: an alternative model for basic and preclinical research. | Gastroenterol Rep (Oxf) | 2023 | 37051577 | PubTator, text mining | PubMed |
| Application of Human Stem Cells to Model Genetic Sensorineural Hearing Loss and Meniere Disease. | Cells | 2023 | 37048061 | PubTator, text mining | PubMed |
| Airway and Lung Organoids from Human-Induced Pluripotent Stem Cells Can Be Used to Assess CFTR Conductance. | Int J Mol Sci | 2023 | 37047264 | PubTator, text mining | PubMed |
| The Cell Biology of Metastatic Invasion in Pancreatic Cancer: Updates and Mechanistic Insights. | Cancers (Basel) | 2023 | 37046830 | PubTator, text mining | PubMed |
Patient Derived Organoids (PDOs), Extracellular Matrix (ECM), Tumor Microenvironment (TME) and Drug Screening: State of the Art and Clinical Implications of Ovarian Cancer Organoids in the Era of Precision Medicine. | Cancers (Basel) | 2023 | 37046719 | PubTator, text mining | PubMed |
| Heterozygous Variants in FREM2 Are Associated with Mesiodens, Supernumerary Teeth, Oral Exostoses, and Odontomas. | Diagnostics (Basel) | 2023 | 37046432 | PubTator, text mining | PubMed |
| METTL3 enhances dentinogenesis differentiation of dental pulp stem cells via increasing GDF6 and STC1 mRNA stability. | BMC Oral Health | 2023 | 37041485 | PubTator, text mining | PubMed |
| Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction. | Nat Commun | 2023 | 37024479 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2255/papers?page=24